The Patent Finder

Innovative Discovery of Therapeutic, Diagnostic, and Antibody Compositions Related to Protein Fragments of Histidyl-Trna Synthetases

Atyr Pharma, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 4 of these applications claim priority to application 13/809,757, filed Apr 29, 2013. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 9,422,539Innovative Discovery of Therapeutic, Diagnostic, and Antibody Compositions Related to Protein Fragments of Histidyl-Trna Synthetases
In force
 · Medium confidence
Atyr Pharma, Inc.In force
Medium confidence
US 9,637,730Innovative Discovery of Therapeutic, Diagnostic, and Antibody Compositions Related to Protein Fragments of Histidyl-Trna Synthetases
In force
 · Medium confidence
Atyr Pharma, Inc.In force
Medium confidence
US 10,196,628Innovative Discovery of Therapeutic, Diagnostic, and Antibody Compositions Related to Protein Fragments of Histidyl-Trna Synthetases
In force
 · Medium confidence
Atyr Pharma, Inc.In force
Medium confidence
US 10,669,533Innovative Discovery of Therapeutic, Diagnostic, and Antibody Compositions Related to Protein Fragments of Histidyl-Trna Synthetases
In force
 · Medium confidence
Atyr Pharma, Inc.In force
Medium confidence
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited